CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2014; 35(04): 281-287
DOI: 10.4103/0971-5851.144990
ORIGINAL ARTICLE

Immediate treatment effects of high-dose methotrexate and cranial irradiation on neuropsychological functions of children treated for acute lymphoblastic leukemia at a regional cancer center

Sundaramoorthy Chidambaram
Department of Psycho-Oncology, Cancer Institute (WIA), Chennai, India
,
Arun Seshachalam
GVN Cancer Hospital, Trichy, Tamil Nadu, India
,
Vidhubala Elangovan
Department of Psycho-Oncology, Cancer Institute (WIA), Chennai, India
,
Rejiv Rajendranath
Department of Medical Oncology, Cancer Institute (WIA), Chennai, India
› Author Affiliations

Abstract

Context: Overall cure rates for pediatric acute lymphoblastic leukemia (ALL) have improved; however, the neuropsychological sequelae of ALL treatment have not been adequately documented in India. Aims: The present study assesses the immediate effects of ALL treatment on neuropsychological functioning, at the Regional Cancer Center in Chennai, South India. Materials and Methods: Newly diagnosed with ALL patients (n = 24) (aged 6-15 years; 13M:11F) registered between March 2008 and February 2009 were included. Patients who had received high-dose methotrexate (HD-MTX) and cranial radiotherapy (CRT) as part of their treatment were enrolled for the study. Neurocognitive assessments were done to assess various functions such as performance intelligence, visuo-perception, visuo-spatial, perceptual organization, processing speed, planning, working memory, and immediate verbal memory (IVM) (Malin′s intelligence scale); verbal fluency (ideation fluency test) and verbal attention (vigilance test). Three assessments were done during induction (baseline), after re-induction phase (second) and during the maintenance phase (third). Results: The patients performed significantly worse in the third assessment (mean duration from diagnosis 17.48 months) on performance intelligence quotient (PIQ), visuo-perception, visuo-spatial, processing speed, planning, IVM, verbal attention, and verbal fluency (P < 0.05), there were no significant changes observed in visuo-perceptual organization and working memory (P > 0.05). Significant difference was observed between age groups 6 and 10 (41.7%) and 11-15 years (58.3%) in perceptual organization, verbal fluency, and verbal attention (P < 0.05) and no gender difference was observed across the three assessments (P > 0.05). Conclusions: Combining HD MTX and CRT had an immediate effect on neuropsychological sequelae among the children with ALL, however, long-term evaluation is recommended to study the long-term effects.



Publication History

Article published online:
19 July 2021

© 2014. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009;46:264-73.
  • 2 Copeland DR, Dowell RE Jr, Fletcher JM, Bordeaux JD, Sullivan MP, Jaffe N, et al. Neuropsychological effects of childhood cancer treatment. J Child Neurol 1988;3:53-62.
  • 3 Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000;15:603-30.
  • 4 Buizer AI, de Sonneville LM, Veerman AJ. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: A critical review of the literature. Pediatr Blood Cancer 2009;52:447-54.
  • 5 Campbell LK, Scaduto M, Van Slyke D, Niarhos F, Whitlock JA, Compas BE. Executive function, coping, and behavior in survivors of childhood acute lymphocytic leukemia. J Pediatr Psychol 2009;34:317-27.
  • 6 Rowland JH, Glidewell OJ, Sibley RF, Holland JC, Tull R, Berman A, et al. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol 1984;2:1327-35.
  • 7 Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006;24:3858-64.
  • 8 Malin AJ. Manual for Malin′s Intelligence Scale for Indian Children (MISIC). Lucknow: Indian Psychological Corporation; 1969.
  • 9 Mukundan CR. NIMHANS Neuropsychological Battery: test Description, Instructions, Clinical Data and Interpretation. NIMHANS, India, Bangalore: NIMHANS Publications; 1996.
  • 10 Strub RL, Black FW. The Mental Status Examination in Neurology. 3 rd ed. New Delhi: Jaypee Brothers Medical Publishers (p) Ltd.; 1995.
  • 11 Copeland DR. Neuropsychological and psychosocial effects of childhood leukemia and its treatment. CA Cancer J Clin 1992;42:283-95.
  • 12 Jain Y, Choudhry VP, Arya LS, Mehta M. Neuropsychological abnormalities following CNS prophylaxis in children with acute lymphatic leukemia. Indian J Pediatr 1993;60:675-81.
  • 13 Abraham A, Appaji L. Cognitive assessment of children with acute lymphoblastic leukemia: Preliminary findings. Indian J Med Paediatr Oncol 2009;30:14-9.
  • 14 Bhattacharya B, Marwaha RK, Malhotra S, Pershad D. Intellectual functions in childhood malignant disorders. Indian Pediatr 1995;32:869-75.
  • 15 Anderson V, Smibert E, Ekert H, Godber T. Intellectual, educational, and behavioural sequelae after cranial irradiation and chemotherapy. Arch Dis Child 1994;70:476-83.
  • 16 Ochs J, Mulhern R, Fairclough D, Parvey L, Whitaker J, Ch′ien L, et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991;9:145-51.
  • 17 Brown RT, Madan-Swain A, Pais R, Lambert RG, Baldwin K, Casey R, et al. Cognitive status of children treated with central nervous system prophylactic chemotherapy for acute lymphocytic leukemia. Arch Clin Neuropsychol 1992;7:481-97.
  • 18 Espy KA, Moore IM, Kaufmann PM, Kramer JH, Matthay K, Hutter JJ. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: A prospective study. J Pediatr Psychol 2001;26:1-9.
  • 19 Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL therapy in childhood. Part III: Neuropsychological performance in long-term survivors of childhood ALL: Impairments of concentration, attention, and memory. Med Pediatr Oncol 2002;38:320-8.
  • 20 Giralt J, Ortega JJ, Olive T, Verges R, Forio I, Salvador L. Long-term neuropsychologic sequelae of childhood leukemia: Comparison of two CNS prophylactic regimens. Int J Radiat Oncol Biol Phys 1992;24:49-53.
  • 21 Reddick WE, Shan ZY, Glass JO, Helton S, Xiong X, Wu S, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006;106:941-9.